We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

101 hedge funds and large institutions have $269M invested in Adverum Biotechnologies in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,032% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $237K

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

40% more capital invested

Capital invested by funds: $192M → $269M (+$77.6M)

1% more funds holding

Funds holding: 100 → 101 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0.38% less ownership

Funds ownership: 5.89% → 5.51% (-0.38%)

Holders
101
Holders Change
+1
Holders Change %
+1%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
36
Reduced
25
Closed
16
Calls
$2.68M
Puts
$237K
Net Calls
+$2.45M
Net Calls Change
-$554K

Top Buyers

Rank Fund Capital Flow
1
WM
WS Management
Florida
+$6.46M
2
BlackRock
BlackRock
New York
+$2.15M
3
MWNA
Marshall Wace North America
New York
+$2.13M
4
AC
Ascend Capital
California
+$1.94M
5
Primecap Management
Primecap Management
California
+$1.86M

Top Sellers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
-$8.49M
2
Citadel Advisors
Citadel Advisors
Florida
-$6.93M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.62M
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$4.22M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$1.29M -$39.9K -710 -3%
Deutsche Bank
27
Deutsche Bank
Germany
$1.19M -$741K -13,201 -40%
BCM
28
Bridgeway Capital Management
Texas
$1.15M – – –
Two Sigma Investments
29
Two Sigma Investments
New York
$1.12M -$1.04M -18,560 -50%
RI
30
RTW Investments
New York
$1.12M +$47.5K +845 +5%
Axa
31
Axa
France
$1.02M +$26.7K +476 +3%
ECM
32
Endurant Capital Management
California
$1.02M +$948K +16,884 New
Millennium Management
33
Millennium Management
New York
$1M +$56.9K +1,013 +7%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$948K -$28.1K -500 -3%
PP
35
PDT Partners
New York
$947K -$298K -5,310 -25%
RPAM
36
Rhenman & Partners Asset Management
Sweden
$931K – – –
HCM
37
Highbridge Capital Management
New York
$908K -$8.49M -151,199 -91%
CI
38
Cowen Inc
New York
$908K +$449K +8,000 +114%
Victory Capital Management
39
Victory Capital Management
Texas
$888K -$45.2K -804 -5%
AQR Capital Management
40
AQR Capital Management
Connecticut
$841K +$586K +10,431 +300%
TA
41
Teachers Advisors
New York
$713K +$74.6K +1,329 +13%
Charles Schwab
42
Charles Schwab
California
$688K – – –
AAP
43
Ardsley Advisory Partners
Connecticut
$666K – – –
TCIM
44
TIAA CREF Investment Management
New York
$658K -$68.7K -1,224 -10%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$649K +$399K +7,100 +196%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$507K +$3.09K +55 +0.7%
VEA
47
Virtus ETF Advisers
New York
$502K -$342K -6,095 -42%
AG
48
Algert Global
California
$481K -$16K -285 -3%
OAM
49
Oxford Asset Management
United Kingdom
$466K -$756K -13,454 -64%
SFM
50
Sphera Funds Management
Israel
$454K +$421K +7,500 New
1
2
3 4 5

ADVM Hedge Fund Activity: Q3 2018 in Review

101 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2018, worth a combined $269M — up 40% from $192M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ADVM positions and 16 closed out — a net gain of 1 holder — while 36 added to existing stakes and 25 trimmed.

The largest buyer was WS Management, opening a new position worth an estimated $6.46M. The largest seller was Highbridge Capital Management, cutting an estimated $8.49M.

  • 101 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2018, up from 100 in Q2 2018.
  • Funds reported $269M of Adverum Biotechnologies stock for Q3 2018, up 40% quarter-over-quarter.
  • 17 funds opened new Adverum Biotechnologies positions in Q3 2018 and 16 closed out, a net change of +1 holder.
  • The largest Adverum Biotechnologies buyer in Q3 2018 was WS Management, an estimated $6.46M added.
  • The largest Adverum Biotechnologies seller in Q3 2018 was Highbridge Capital Management, an estimated $8.49M sold.

Based on aggregated 13F filings for Q3 2018.